Thermo Fisher Scientific announces new business division

posted by Phill Allen

February, 19th, 2014

Company News Pharmaceutical Industry News

Thermo Fisher Scientific has announced details of a new business division following its $13.6bn acquisition of Life Technologies Corporation earlier in January.
Thermo, the world’s largest laboratory equipment maker, will incorporate Life Technologies into Life Sciences Solutions along with its existing Biosciences businesses.
As part of the changes, the company’s financial performance will be reported by way of four core segments.
These include:
1. The Life Sciences Solutions segment which is made up of the majority of the former Life Technologies and Thermo Fisher Biosciences businesses
2. Thermo Fisher’s Global Chemicals business which is set to migrate from the Biosciences brand to to the Laboratory Products and Services Segment
3. Thermo Fisher’s Analytical Technologies Segment which will be renamed Analytical Instruments
4. And, within Life Technologies, two smaller diagnostics businesses which will merge into the Specialty Diagnostics Segment
Mark Stevenson, who formerly served as chief operating officer of Life Technologies, has been named executive vice president of the division.

Related reading:

 

TAGS: Life Technologies Corporation, Thermo Fisher Scientific,

SHARE:

Author

Phill Allen

Managing Director

Phill is an innovative thinker particularly in fluid management. His expertise lies in ensuring the seamless flow of pharmaceutical liquid logistics, whether it's optimising current processes or pioneering new approaches.

Bioprocess tubing - How to choose the right type
ALLpaQ Innovation Company News Product News

Bioprocess tubing - How to choose the right type

Tubing is an essential component of any bioprocess application and helps to transfer fluids throughout the upstream and downstream stages. […]

Jan 19th, 2026

Why choose ALLpaQ for your fluid management needs?
ALLpaQ Innovation Company News

Why choose ALLpaQ for your fluid management needs?

Nov 12th, 2025